A Healthy Trade (In More Ways Than One)
With the IBB biotechnology ETF poised to have its best quarter in six years and analysts seeing further upside for the space, biotech appears to… Read More »A Healthy Trade (In More Ways Than One)
With the IBB biotechnology ETF poised to have its best quarter in six years and analysts seeing further upside for the space, biotech appears to… Read More »A Healthy Trade (In More Ways Than One)